Details
| Stereochemistry | ACHIRAL |
| Molecular Formula | 2C16H19IN2O5.Tc |
| Molecular Weight | 991.3801 |
| Optical Activity | NONE |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
[99Tc+4].CCC1=C(NC(=O)CN(CC([O-])=O)CC([O-])=O)C(CC)=C(I)C=C1.CCC2=C(NC(=O)CN(CC([O-])=O)CC([O-])=O)C(CC)=C(I)C=C2
InChI
InChIKey=KKRISYPFLIKFPU-FCHARDOESA-J
InChI=1S/2C16H21IN2O5.Tc/c2*1-3-10-5-6-12(17)11(4-2)16(10)18-13(20)7-19(8-14(21)22)9-15(23)24;/h2*5-6H,3-4,7-9H2,1-2H3,(H,18,20)(H,21,22)(H,23,24);/q;;+4/p-4/i;;1+1
| Molecular Formula | Tc |
| Molecular Weight | 98.9063 |
| Charge | 4 |
| Count |
|
| Stereochemistry | ACHIRAL |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Optical Activity | NONE |
| Molecular Formula | C16H19IN2O5 |
| Molecular Weight | 446.2369 |
| Charge | -2 |
| Count |
|
| Stereochemistry | ACHIRAL |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Optical Activity | NONE |
DescriptionCurator's Comment: description was created based on several sources, including
https://www.ncbi.nlm.nih.gov/books/NBK215133/ | https://www.iaea.org/OurWork/ST/NE/NEFW/Technical-Areas/RRS/documents /mo99/WORKINGMATERIALSmo99CM.pdf | https://www.ncbi.nlm.nih.gov/pubmed/27854401
Curator's Comment: description was created based on several sources, including
https://www.ncbi.nlm.nih.gov/books/NBK215133/ | https://www.iaea.org/OurWork/ST/NE/NEFW/Technical-Areas/RRS/documents /mo99/WORKINGMATERIALSmo99CM.pdf | https://www.ncbi.nlm.nih.gov/pubmed/27854401
Molybdenum-99 (99Mo, half-life = 66 h) is a parent radionuclide of a diagnostic nuclear isotope. It decays in technetium-99 m (half-life = 6 h), which is used in over 30 million procedures per year around the world. Between 95 and 98 percent of Mo-99 is currently being produced using highly enriched uranium (HEU) targets. Other medical isotopes such as iodine-131 (I-131) and xenon-133 (Xe-133) are by-products of the Mo-99 production process and will be sufficiently available if Mo-99 is available.
Approval Year
Conditions
| Condition | Modality | Targets | Highest Phase | Product |
|---|---|---|---|---|
| Diagnostic | OSTEOLITE Approved UseUnknown Launch Date1977 |
|||
| Diagnostic | DRAXIMAGE MDP-10 Approved UseMDP-25 (Kit for the Preparation of Technetium Tc 99m Medronate) may be used as a bone imaging agent to delineate areas of altered osteogenesis. Launch Date1978 |
| Substance Class |
Chemical
Created
by
admin
on
Edited
Sat Dec 16 11:13:27 GMT 2023
by
admin
on
Sat Dec 16 11:13:27 GMT 2023
|
| Record UNII |
M1W073D1KR
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Common Name | English |
| Classification Tree | Code System | Code | ||
|---|---|---|---|---|
|
WHO-ATC |
V09DA05
Created by
admin on Sat Dec 16 11:13:27 GMT 2023 , Edited by admin on Sat Dec 16 11:13:27 GMT 2023
|
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
117587538
Created by
admin on Sat Dec 16 11:13:27 GMT 2023 , Edited by admin on Sat Dec 16 11:13:27 GMT 2023
|
PRIMARY | |||
|
M1W073D1KR
Created by
admin on Sat Dec 16 11:13:27 GMT 2023 , Edited by admin on Sat Dec 16 11:13:27 GMT 2023
|
PRIMARY | |||
|
CHEMBL3707261
Created by
admin on Sat Dec 16 11:13:27 GMT 2023 , Edited by admin on Sat Dec 16 11:13:27 GMT 2023
|
PRIMARY |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
ACTIVE MOIETY | |||
|
|
ACTIVE MOIETY |
